Annual Retained Earnings
-$369.83 M
-$17.75 M-5.04%
01 December 2023
Summary:
COSCIENS Biopharma annual retained earnings is currently -$369.83 million, with the most recent change of -$17.75 million (-5.04%) on 01 December 2023. During the last 3 years, it has fallen by -$47.17 million (-14.62%).CSCI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$5.16 M
-$6.69 M-436.46%
01 September 2024
Summary:
COSCIENS Biopharma quarterly retained earnings is currently -$5.16 million, with the most recent change of -$6.69 million (-436.46%) on 01 September 2024. Over the past year, it has dropped by -$11.26 million (-184.47%).CSCI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.0% | -184.5% |
| 3 y3 years | -14.6% | -226.9% |
| 5 y5 years | -19.4% | -724.0% |
CSCI Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | <-9999.0% | -164.3% |
COSCIENS Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$5.16 M(-436.5%) |
| June 2024 | - | $1.53 M(-51.6%) |
| Mar 2024 | - | $3.17 M(-31.9%) |
| Dec 2023 | -$369.83 M(+5.0%) | $4.65 M(-23.8%) |
| Sept 2023 | - | $6.11 M(-13.4%) |
| June 2023 | - | $7.05 M(-9.2%) |
| Mar 2023 | - | $7.76 M(-3.2%) |
| Dec 2022 | -$352.08 M(+5.2%) | $8.02 M(+4.6%) |
| Sept 2022 | - | $7.66 M(+2.7%) |
| June 2022 | - | $7.46 M(+17.1%) |
| Mar 2022 | - | $6.37 M(+25.3%) |
| Dec 2021 | -$334.62 M(+3.7%) | $5.08 M(+25.1%) |
| Sept 2021 | - | $4.06 M(+17.0%) |
| June 2021 | - | $3.47 M(+20.8%) |
| Mar 2021 | - | $2.88 M(+17.7%) |
| Dec 2020 | -$322.66 M(+1.8%) | $2.44 M(-10.5%) |
| Sept 2020 | - | $2.73 M(+7.7%) |
| June 2020 | - | $2.54 M(+50.7%) |
| Mar 2020 | - | $1.68 M(+74.4%) |
| Dec 2019 | -$316.89 M(+2.3%) | $964.90 K(+16.7%) |
| Sept 2019 | - | $826.60 K(-9.4%) |
| June 2019 | - | $912.40 K(-30.6%) |
| Mar 2019 | - | $1.32 M(-25.1%) |
| Dec 2018 | -$309.78 M(-1.4%) | $1.76 M(+16.5%) |
| Sept 2018 | - | $1.51 M(-11.7%) |
| June 2018 | - | $1.71 M(-8.6%) |
| Mar 2018 | - | $1.87 M(-13.2%) |
| Dec 2017 | -$314.16 M(+5.4%) | $2.15 M(-38.6%) |
| Sept 2017 | - | $3.51 M(+12.5%) |
| June 2017 | - | $3.12 M(+12.8%) |
| Mar 2017 | - | $2.76 M(+1.3%) |
| Dec 2016 | -$298.06 M(+9.7%) | $2.73 M(+4.4%) |
| Sept 2016 | - | $2.61 M(+21.2%) |
| June 2016 | - | $2.16 M(+142.5%) |
| Mar 2016 | - | $889.10 K(-2182.2%) |
| Dec 2015 | -$271.62 M(+22.2%) | -$42.70 K(-98.4%) |
| Sept 2015 | - | -$2.62 M(-28.1%) |
| June 2015 | - | -$3.64 M(-10.8%) |
| Mar 2015 | - | -$4.08 M(-4.5%) |
| Dec 2014 | -$222.32 M(+9.0%) | -$4.28 M(-5.7%) |
| Sept 2014 | - | -$4.53 M(-15.9%) |
| June 2014 | - | -$5.39 M(-6.6%) |
| Mar 2014 | - | -$5.77 M(-6.3%) |
| Dec 2013 | -$203.93 M(-4.3%) | -$6.16 M(-1.6%) |
| Sept 2013 | - | -$6.26 M(+0.1%) |
| June 2013 | - | -$6.25 M(+0.5%) |
| Mar 2013 | - | -$6.22 M(-8.2%) |
| Dec 2012 | -$213.09 M(+12.8%) | -$6.77 M(+2.6%) |
| Sept 2012 | - | -$6.60 M(+5.6%) |
| June 2012 | - | -$6.25 M(+0.6%) |
| Mar 2012 | - | -$6.21 M(+2.4%) |
| Dec 2011 | -$188.97 M(+25.3%) | -$6.07 M(-4.9%) |
| Sept 2011 | - | -$6.38 M(-5.1%) |
| June 2011 | - | -$6.73 M(-1.2%) |
| Mar 2011 | - | -$6.81 M(-0.1%) |
| Dec 2010 | -$150.76 M | -$6.82 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | -$6.87 M(+0.5%) |
| June 2010 | - | -$6.83 M(-6.4%) |
| Mar 2010 | - | -$7.30 M(+3.4%) |
| Dec 2009 | -$127.54 M(+24.0%) | -$7.06 M(+11.7%) |
| Sept 2009 | - | -$6.32 M(+8.7%) |
| June 2009 | - | -$5.82 M(+1.7%) |
| Mar 2009 | - | -$5.72 M(-5.0%) |
| Dec 2008 | -$102.81 M(+139.1%) | -$6.02 M(+7.8%) |
| Sept 2008 | - | -$5.58 M(+4.8%) |
| June 2008 | - | -$5.32 M(+26.5%) |
| Mar 2008 | - | -$4.21 M(+11.9%) |
| Dec 2007 | -$43.00 M(+325.1%) | -$3.76 M(+16.8%) |
| Sept 2007 | - | -$3.22 M(+32.1%) |
| June 2007 | - | -$2.43 M(+19.3%) |
| Mar 2007 | - | -$2.04 M(+2.0%) |
| Dec 2006 | -$10.11 M(-76.6%) | -$2.00 M(+1.1%) |
| Sept 2006 | - | -$1.98 M(+4.3%) |
| June 2006 | - | -$1.90 M(+4.8%) |
| Mar 2006 | - | -$1.81 M(+2.1%) |
| Dec 2005 | -$43.22 M(-19.7%) | -$1.77 M(-5.5%) |
| Sept 2005 | - | -$1.88 M(+11.7%) |
| June 2005 | - | -$1.68 M(-5.9%) |
| Mar 2005 | - | -$1.79 M(+7.1%) |
| Dec 2004 | -$53.80 M(-4.5%) | -$1.67 M(+9.1%) |
| Sept 2004 | - | -$1.53 M(+30.1%) |
| June 2004 | - | -$1.17 M(+3.1%) |
| Mar 2004 | - | -$1.14 M(-8.0%) |
| Dec 2003 | -$56.30 M(+97.6%) | -$1.24 M(+14.1%) |
| Sept 2003 | - | -$1.09 M(-18.7%) |
| June 2003 | - | -$1.33 M(-2.9%) |
| Mar 2003 | - | -$1.37 M(+5.7%) |
| Dec 2002 | -$28.50 M(+137.8%) | -$1.30 M(-2.3%) |
| Sept 2002 | - | -$1.33 M(-95.7%) |
| June 2002 | - | -$31.09 M(+5.0%) |
| Mar 2002 | - | -$29.61 M(+0.1%) |
| Dec 2001 | -$11.99 M(+15.1%) | -$29.59 M(-1.2%) |
| Sept 2001 | - | -$29.96 M(-3.8%) |
| June 2001 | - | -$31.14 M(+4.7%) |
| Mar 2001 | - | -$29.73 M(-4.6%) |
| Dec 2000 | -$10.41 M(+153.2%) | -$31.16 M(+1.1%) |
| Sept 2000 | - | -$30.81 M(-1.2%) |
| June 2000 | - | -$31.19 M(-1.5%) |
| Mar 2000 | - | -$31.67 M(+0.1%) |
| Dec 1999 | -$4.11 M(+216.4%) | -$31.62 M(+2.5%) |
| Sept 1999 | - | -$30.85 M(+0.8%) |
| June 1999 | - | -$30.59 M(+2.6%) |
| Mar 1999 | - | -$29.82 M(+2.2%) |
| Dec 1998 | -$1.30 M(-197.9%) | -$29.18 M(+15.7%) |
| Sept 1998 | - | -$25.22 M(+19.1%) |
| June 1998 | - | -$21.17 M(-3.1%) |
| Mar 1998 | - | -$21.84 M(+1.8%) |
| Dec 1997 | $1.33 M(+1.1%) | -$21.45 M(+73.3%) |
| Sept 1997 | - | -$12.38 M(+13.9%) |
| June 1997 | - | -$10.86 M(+16.2%) |
| Mar 1997 | - | -$9.35 M |
| Dec 1996 | $1.31 M | - |
FAQ
- What is COSCIENS Biopharma annual retained earnings?
- What is the all time high annual retained earnings for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual retained earnings year-on-year change?
- What is COSCIENS Biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly retained earnings year-on-year change?
What is COSCIENS Biopharma annual retained earnings?
The current annual retained earnings of CSCI is -$369.83 M
What is the all time high annual retained earnings for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual retained earnings is $1.33 M
What is COSCIENS Biopharma annual retained earnings year-on-year change?
Over the past year, CSCI annual retained earnings has changed by -$17.75 M (-5.04%)
What is COSCIENS Biopharma quarterly retained earnings?
The current quarterly retained earnings of CSCI is -$5.16 M
What is the all time high quarterly retained earnings for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly retained earnings is $8.02 M
What is COSCIENS Biopharma quarterly retained earnings year-on-year change?
Over the past year, CSCI quarterly retained earnings has changed by -$11.26 M (-184.47%)